Cargando…
Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection
BACKGROUND: Historically, eradication of HCV with interferon-based treatments was linked with decreased incidence of diabetes. While viral clearance with direct acting agents (DAAs) may be associated with acute decreases in fasting glucose levels and hemoglobin A1c (HbA1c), there remains a need for...
Autores principales: | Chaudhury, Chloe, Sheehan, Julia, Chairez, Cheryl, Akoth, Elizabeth, Gross, Chloe, Kattakuzhy, Sarah, Rosenthal, Elana, Kottilil, Shyam, Masur, Henry, Hadigan, Colleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631475/ http://dx.doi.org/10.1093/ofid/ofx163.1751 |
Ejemplares similares
-
1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study
por: Mathur, Poonam, et al.
Publicado: (2018) -
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
por: Tang, Lydia Shuk Yee, et al.
Publicado: (2016) -
Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
por: Shrivastava, Shikha, et al.
Publicado: (2018) -
Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8(+) T-Cell Function
por: Orr, Cody, et al.
Publicado: (2021) -
2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study
por: Rosenthal, Elana S, et al.
Publicado: (2019)